Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
Open | $11.47 |
Close | $11.29 |
Volume / Avg. | 296.75K / 359.09K |
Day Range | 11.23 - 11.65 |
52 Wk Range | 4.60 - 20.90 |
Market Cap | $495.43M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 10.03% |
Days to Cover | 13.24 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.
Other companies in Y-mAbs Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR) and Replimune Group (NASDAQ:REPL).
There is no analysis for Y-mAbs Therapeutics.
Y-mAbs Therapeutics has a consensus price target of $14.33.
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $11.29 last updated Today at July 8, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Y-mAbs Therapeutics.
Y-mAbs Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Y-mAbs Therapeutics.
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.